# Vaccine discussion

Page: https://stenobird.com/podcast/dr-john-campbell-7851784/vaccine-discussion
Text version: https://stenobird.com/podcast/dr-john-campbell-7851784/vaccine-discussion.md
Podcast: [Dr. John Campbell](https://stenobird.com/podcast/dr-john-campbell-7851784)
Published: 2026-09-12T07:00:00+00:00
Episode link: https://traffic.megaphone.fm/VG8787063468.mp3
Audio file: https://traffic.megaphone.fm/VG8787063468.mp3
Processing state: not_requested
JSON: https://stenobird.com/v1/public/podcasts/dr-john-campbell-7851784/episodes/vaccine-discussion
Duration seconds: 1110

## Resource

UK parliament and EU Parliament ONS, 1st November release, UK deaths, week ending 21 October 2022 13,463 15.7% 1,822 excess deaths Deaths involving COVID-19, 5.5% of all UK deaths https://www.bhf.org.uk/-/media/files/what-we-do/influencing-change/tipping-point-bhf-report.pdf?rev=089147572a2c4dd789746b5e6f4ba617&hash=F7141D4C13A10C6C089824892CA59CDE https://hansard.parliament.uk/commons/2022-10-24/debates/FF880636-BC3B-4BDB-A5E0-D6D4B82B2888/Covid-19VaccinesSafety Mr. Andrew Bridgen MP (NW Leicestershire) https://www.youtube.com/watch?v=pfgGCgxGYkk Eurostat https://ec.europa.eu/eurostat/databrowser/view/demo_mexrt/default/table?lang=en https://ec.europa.eu/eurostat/statistics-explained/index.php?title=File:Map01_Excess_Mortality_2022_Aug.png Learn more about your ad choices. Visit megaphone.fm/adchoices

## Actions

- request_transcript: `POST https://stenobird.com/v1/public/podcasts/dr-john-campbell-7851784/episodes/vaccine-discussion/transcription-requests` — Idempotently request low-priority transcript generation for this episode.
- read_markdown: `GET https://stenobird.com/podcast/dr-john-campbell-7851784/vaccine-discussion.md` — Read the agent-friendly Markdown representation of this episode resource.

A page view does not enqueue transcription. Agents should invoke `request_transcript` explicitly when they need this episode processed.

## Transcript

Full transcripts are not published on public pages unless there is a clear rights basis.